Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy

PHASE2CompletedINTERVENTIONAL

Enrollment

330

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Diabetic Neuropathy, Painful

Interventions

DRUG

AGN 203818

3 mg Capsule twice daily for 4 weeks

DRUG

AGN 203818

20 mg Capsule twice daily for 4 weeks

DRUG

AGN 203818

60 mg Capsule twice daily for 4 weeks

DRUG

placebo capsule

Capsule twice daily for 4 weeks

Trial Locations (1)

Tacoma